RxDoctor Payments Data

Lauren Ferris

Gerontology · Roanoke, VANPI 1710447776

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $9,265 of the $11,368 with a category attached, or 81.5%. It is spread thinly across 15 manufacturers, the largest accounting for just 23.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $3,296 and has fallen 51.3% since, to $1,605 in 2025. Among gerontology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,368in general payments, 2019–2025

Across 170 payments — averaging $66.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Medtronic$3K
  • Edwards Lifesciences$2K
  • Irhythm Technologies, Inc.$1K
  • W. L. Gore & Associates, Inc.$767
  • Abbott$521
  • plus $1K from 9 others

What the payments were for

  • Travel & lodging$2,10218%
  • Food & beverage$9,26581%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,368 in reported general payments places this provider in the 95th percentile of 130 gerontology providers in Virginia.

See all gerontology providers in Virginia

Medicare billing

Part B allowed, 2024
$16,702
Medicare patients
181
Services billed
218

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban47$43,549
JardianceEmpagliflozin21$18,555
EntrestoSacubitril/Valsartan21$15,307
ClopidogrelClopidogrel Bisulfate208$2,104
Bumetanide16$654
Metoprolol Succinate36$504
Potassium Chloride30$473
Diltiazem 24hr Er (Cd)Diltiazem Hcl12$461
Warfarin Sodium22$320
Furosemide54$275
Rosuvastatin Calcium18$179
Klor-Con M20Potassium Chloride11$160
Losartan Potassium13$136
Carvedilol16$129
Isosorbide Mononitrate ErIsosorbide Mononitrate13$118

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$57$43,54947 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 130 gerontology providers in Virginia.

Other gerontology in Roanoke

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →